ASPI Subsidiary Noble Africa to Merge with ENDRA, Secures $50M Private Placement

ASP Isotopes (ASPI) announced that its wholly-owned subsidiary, Noble Africa LLC, will merge with a subsidiary of ENDRA Life Sciences. The transaction is designed to establish Noble Africa as a Nasdaq-listed company focused on the Renergen Virginia Gas Project's helium assets. A concurrent private placement is expected to raise approximately $50 million.

Key Details

• Transaction: Noble Africa LLC will merge with an ENDRA Life Sciences subsidiary. The combined entity will be named Noble Africa Inc. and apply to trade on Nasdaq under the ticker "NOBA".
• Concurrent Financing: Noble Africa has secured commitments for a private placement expected to provide gross proceeds of approximately $50 million. This includes a $20 million lead investment from ASPI.
• Post-Merger Ownership: Upon closing, ownership of the combined company is expected to be approximately 89% by ASP Isotopes, 3% by pre-closing ENDRA stockholders, and 7% by other private placement investors.
• Timeline: The merger has been approved by the boards of both companies and is expected to close in the third or fourth quarter of 2026, subject to customary closing conditions, including approval by ENDRA's stockholders.